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PreviewsNature’s Protection Racket
(2S)-4-amino-2-hydroxybutyrate (AHBA) is a side chain
that is important for the antibiotic activities of amino-
glycosides. The elucidation of the biosynthetic path-
way to AHBA, by Spencer et al. in this issue of Chem-
istry & Biology [1], reveals several surprises and will
facilitate biosynthetic engineering of new improved
aminoglycoside antibiotics.
The use of protecting groups to mask functional groups
within a molecule, and thereby facilitate regioselective
transformations, has been one of the cornerstones of
organic synthesis [2]. Nowhere has this been more evi-
dent than in the total synthesis of natural products,
which are typically rich in diverse, and often delicate,
functionality [3]. However, the use of protecting groups
is inefficient, adding extra steps to a synthetic pathway.
As a result, many of today’s synthetic chemists strive
to develop new reactions that are sufficiently mild and
selective to obviate the need for protecting groups. In
this respect, the chemist can only aspire to achieve the
kind of selectivity and efficiency afforded by enzymes.
After all, evidence suggests that nature has been bio-
synthesizing natural products, without the need for pro-
tecting groups, for over a billion years. In spite of this,
there are rare examples when even nature resorts to
using protecting groups to facilitate a subsequent en-
zymatic transformation, particularly when a substrate
may otherwise undergo spontaneous nonenzymatic
cyclization. For example, in lysine biosynthesis (Figure
1A), the hydrated open-chain form of the precursor
L-tetrahydrodipicolinate (L-THDP, 1) is acylated to give
N-acyl-α-amino--ketopimelate 2 [4, 5]. The N-acyl-
blocking group, which is succinate in E. coli or acetyl
in some other prokaryotes, frees the -keto group, facil-
itating a subsequent transamination to give N-acyl dia-
minopimelate (DAP) 3. Hydrolysis of the acyl-protecting
group followed by epimerization and decarboxylation
gives lysine. Similarly in the biosynthesis of arginine in
E. coli, glutamate is N-acetylated before the γ-carboxyl
group is phosphorylated and reduced to N-acetylgluta-
mate-γ-semialdehyde. Transamination of the aldehyde
followed by hydrolysis of the acetyl-protecting group
reveals ornithine, which is transformed to arginine via
the urea cycle [6]. In the absence of the N-acetyl-pro-
tecting group, glutamate-γ-semialdehyde spontane-
ously cyclizes and is reduced, by pyrroline-5-carboxyl-
ate reductase, to give proline.
In addition to amino acid metabolism, recent studies
on the catabolism of amines have revealed other exam-
ples of natural protective-group chemistry. For instance
(Figure 1B), putrescine 4 is degraded in E. coli by first
protecting one of the amino groups with γ-glutamate 5.
This allows oxidation of the other amino group to the
aldehyde 6, which would spontaneously cyclize in the
absence of the protecting group. Further oxidation to
the acid 7 and hydrolysis of the glutamyl group givesγ-aminobutyrate (GABA) [7]. Finally, in the degradation
of isopropylamine to L-alaninol by Pseudomonas spe-
cies, the amine is first protected with a γ-glutamyl
group before hydroxylation and subsequent hydrolysis
of the protecting group [8].
In this issue of Chemistry & Biology, Spencer et al. [1]
have elucidated the biosynthetic pathway to the AHBA
side chain of the aminoglycoside butirosin (Figure 1C).
Intriguingly, this pathway provides another example in
which nature has apparently evolved a protective-group
strategy. In AHBA biosynthesis, the phosphopantatheine
group of BtrI, an acyl-carrier protein (ACP), is γ-L-gluta-
mylated by an ATP-dependent ligase, BtrJ. Activation of
the γ-carboxylate occurs through the formation of an
acyl-phosphate intermediate with release of ADP, which
is distinct from the activation step in the transfer of
amino acids to peptidyl-carrier proteins (PCPs), which
occurs via aminoacyl adenylate intermediates. Decar-
boxylation of γ-L-Glu-S-BtrI 8 gives GABA-S-BtrI 9,
which surprisingly undergoes γ-L-glutamylation, in a
reaction that is also catalyzed by BtrJ. Subsequent
α-hydroxylation of 10 gives γ-L-Glu-AHBA-S-BtrI 11.
Presumably, the dual function enzyme BtrJ catalyzes
the second acylation to protect the γ-amino group of
GABA-S-BtrI or AHBA-S-BtrI from cyclizing onto the
activated thioester, which would result in the loss of
GABA or AHBA from the ACP. Although the mode of
transfer of AHBA to the aminoglycoside core was not
determined, it was proposed that the enzymes BtrG or
BtrH catalyze the acyl-transfer with hydrolysis of the
γ-glutamyl group occurring in the last step to give buti-
rosin. Therefore, the γ-glutamyl group might also serve
to protect the producing organism from the antibiotic
effects of butirosin [1].
The pathway to AHBA also provides additional evi-
dence of the important role that carrier proteins play in
secondary metabolism. In addition to the well-charac-
terized role of ACPs and PCPs in the biosynthesis of
fatty acids, polyketides, and nonribosomal peptides, it
has become apparent that phosphopantetheinylated
carrier proteins play a wide role in the biosynthesis of
other classes of natural products. For example, PCPs
and adenylation-PCP didomains are used to activate
and tether proline, tyrosine, and histidine in the biosyn-
thesis of undecylprodigiosin [9], novobiocin [10], and
nikkomycin [11], respectively. As with the biosynthesis
of AHBA, the carrier proteins in these examples serve
to sequester proteinogenic amino acids, thereby divert-
ing a fraction of the available primary metabolic pool to
secondary metabolism [12]. Any subsequent intermedi-
ates that are generated by downstream tailoring en-
zymes remain tethered to the carrier protein and are
therefore unable to interfere with existing primary meta-
bolic pathways. This could include the aberrant incor-
poration of nonproteinogenic amino acids into proteins
during the course of biological evolution [13]. The car-
rier protein can further serve to channel and protect any
unstable intermediates, so-called “hot potatoes” [14].
Also, given that the carrier protein is a covalent ex-
tension of the substrate, protein-protein interactions
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612Figure 1. Examples of Protective-Group Chemistry Employed by Nature
(A) Biosynthesis of L-lysine in bacteria [4, 5]: (i) THDP N-Acyltransferase; (ii) N-Acyl-DAP aminotransferase; (iii) N-Acyl-DAP deacylase; (iv)
DAP epimerase; and (v) DAP decarboxylase.
(B) Putrescine degradation in E. coli [7]: (vi) YcjK, γ-glutamyl-putrescine synthetase; (vii) OrdL, γ-glutamyl-putrescine oxidase; (viii) AldH,
γ-glutamyl-aminobutyraldehyde dehydrogenase; and (ix) YcjL, γ-glutamyl-GABA hydrolase.
(C) Biosynthesis of the AHBA side chain of butirosin: see this issue of Chemistry & Biology [1].undoubtedly serve to modulate the activities of down- o
pstream tailoring enzymes. Finally, the electron-withdraw-
ing thioester bond between intermediates and the r
bphosphopantetheine group of the carrier protein not
only activates the carboxyl group of substrate for sub- h
rsequent cyclization [10], reduction [12], hydrolysis [11],
or in the case of AHBA, amino acylation [1] but also t
fstabilizes α-carbanions facilitating α,β-oxidations [1,
12]. Indeed, the general utility of phosphopantethein- n
oylated carrier proteins extends beyond metabolism in
prokaryotes and lower eukaryotes and has recently
been demonstrated in higher eukaryotes. For example, J
a PCP-like domain within α-aminoadipate-semialde- S
hyde dehydrogenase is implicated in the degradation T
of lysine in humans [15]. Similarly, in Drosophila, a PCP- S
containing enzyme (Ebony) has been shown to activate Mβ-alanine for a subsequent acylation of histamine [16]. U
The emergence of bacterial resistance to naturally
occurring aminoglycoside antibiotics has fueled the
search for new analogs [17]. The AHBA side chain is S
a useful pharmacophore in the design of new analogs
because it affords butirosin and semisynthetic amino-
glycosides increased protection against resistance en-
zymes, which chemically modify this class of antibiot-
ics [17]. Despite this, the total synthesis and even the
semisynthesis of aminoglycoside analogs is compli-
cated by the need to protect and differentiate the multi-
ple reactive-amino and hydroxyl groups. The develop-
ment of methods that enable engineered biosynthesisf new aminoglycoside analogs is, thus, extremely im-
ortant. Although the enzyme that transfers AHBA to
ibostamycin in the biosynthesis of butirosin has yet to
e identified, the findings of Spencer et al. [1] make it
ighly likely that AHBA will be transferred from the car-
ier protein BtrI, remarkably with a γ-glutamyl N-pro-
ecting group still intact. This discovery should spark
uture research toward the engineered biosynthesis of
ovel aminoglycoside antibiotics incorporating AHBA
r related acyl side chains.
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